CSPC Pharmaceutical Group...

PNK: CSPCY · Real-Time Price · USD
3.48
0.11 (3.26%)
At close: May 23, 2025, 3:18 PM

CSPC Pharmaceutical Statistics

Share Statistics

CSPC Pharmaceutical has 2.91B shares outstanding. The number of shares has increased by -2.88% in one year.

Shares Outstanding 2.91B
Shares Change (YoY) -2.88%
Shares Change (QoQ) -1.72%
Owned by Institutions (%) n/a
Shares Floating n/a
Failed to Deliver (FTD) Shares 14,250
FTD / Avg. Volume 53.55%

Short Selling Information

The latest short interest is 3.32K, so 0% of the outstanding shares have been sold short.

Short Interest 3.32K
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is 12.43 and the forward PE ratio is null. CSPC Pharmaceutical's PEG ratio is -0.39.

PE Ratio 12.43
Forward PE n/a
PS Ratio 1.85
Forward PS 0
PB Ratio 1.67
P/FCF Ratio 28.99
PEG Ratio -0.39
Financial Ratio History

Enterprise Valuation

CSPC Pharmaceutical has an Enterprise Value (EV) of 208.91B.

EV / Sales 7.2
EV / EBITDA 30.01
EV / EBIT 46.07
EV / FCF 112.57

Financial Position

The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.02.

Current Ratio 2.27
Quick Ratio 1.95
Debt / Equity 0.02
Debt / EBITDA 0.07
Debt / FCF 0.27
Interest Coverage 122.87

Financial Efficiency

Return on Equity is 13.41% and Return on Invested Capital is 11.85%.

Return on Equity 13.41%
Return on Assets 9.75%
Return on Invested Capital 11.85%
Revenue Per Employee $1,355,572.62
Profits Per Employee $202,244.63
Employee Count 21,400
Asset Turnover 0.65
Inventory Turnover 2.78

Taxes

Income Tax 1.24B
Effective Tax Rate 22.23%

Stock Price Statistics

The stock price has increased by 5.31% in the last 52 weeks. The beta is 0.72, so CSPC Pharmaceutical's price volatility has been higher than the market average.

Beta 0.72
52-Week Price Change 5.31%
50-Day Moving Average 2.79
200-Day Moving Average 2.65
Relative Strength Index (RSI) 69.02
Average Volume (20 Days) 26,611

Income Statement

In the last 12 months, CSPC Pharmaceutical had revenue of 29.01B and earned 4.33B in profits. Earnings per share was 1.48.

Revenue 29.01B
Gross Profit 20.3B
Operating Income 5.37B
Net Income 4.33B
EBITDA 6.96B
EBIT 5.62B
Earnings Per Share (EPS) 1.48
Full Income Statement

Balance Sheet

The company has 6.78B in cash and 507.33M in debt, giving a net cash position of 6.27B.

Cash & Cash Equivalents 6.78B
Total Debt 507.33M
Net Cash 6.27B
Retained Earnings 23.34B
Total Assets 44.39B
Working Capital 12.25B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.53B and capital expenditures -2.68B, giving a free cash flow of 1.86B.

Operating Cash Flow 4.53B
Capital Expenditures -2.68B
Free Cash Flow 1.86B
FCF Per Share 0.16
Full Cash Flow Statement

Margins

Gross margin is 69.97%, with operating and profit margins of 18.5% and 14.92%.

Gross Margin 69.97%
Operating Margin 18.5%
Pretax Margin 19.23%
Profit Margin 14.92%
EBITDA Margin 24%
EBIT Margin 18.5%
FCF Margin 6.4%

Dividends & Yields

CSPCY pays an annual dividend of $0.15, which amounts to a dividend yield of 3.11%.

Dividend Per Share $0.15
Dividend Yield 3.11%
Dividend Growth (YoY) 28.57%
Payout Ratio 77%
Earnings Yield 8.05%
FCF Yield 0.86%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for CSPCY.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Dec 10, 2020. It was a forward split with a ratio of 8:5.

Last Split Date Dec 10, 2020
Split Type forward
Split Ratio 8:5

Scores

Altman Z-Score 3.14
Piotroski F-Score 8